Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Statistical Measurement [Domain] Statistical Measurement [Domain] Registered Direct Warrants, 180 Day, November 2024 Registered Direct Warrants, 180 Day, November 2024 [Member] Registered Direct Warrants, 180 Day, November 2024 Restricted cash included in prepaid expenses and other current assets Restricted Cash, Current Award Timing Predetermined Award Timing Predetermined [Flag] Yang (Cindy) Cao - 2024 Trading Plan [Member] Yang (Cindy) Cao - 2024 Trading Plan Entity File Number Entity File Number Contingent cash collateral funded Contingent Cash Collateral Funded Contingent Cash Collateral Funded Additional Paid-in Capital Additional Paid-in Capital [Member] Percentage of cumulative purchaser payments less total revenue interest payments due Percentage of Cumulative Purchaser Payments Less Total Revenue Interest Payments Due Percentage of Cumulative Purchaser Payments Less Total Revenue Interest Payments Due Tabular List, Table Tabular List [Table Text Block] Number of securities issued or issuable (in shares) Business Combination, Consideration Transferred, Equity Interest, Share Issued, Number of Shares Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Accounts payable Increase (Decrease) in Accounts Payable PAD PAD [Member] PAD Contingent Earnout Liability Contingent Earnout Liability Contingent Earnout Liability [Member] Represents the information pertaining to contingent earnout liability. Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Warrants (in shares) Class of Warrant or Right, Outstanding Net income (loss) per share attributable to common stockholders, basic (in dollars per share) Net income (loss) attributable to common stockholders - basic (in dollars per share) Earnings Per Share, Basic Adjustment to Compensation: Adjustment to Compensation [Axis] Related Party Transactions Related Party Transactions Disclosure [Text Block] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Reserved common stock for future issuances (in shares) Common Stock, Capital Shares Reserved for Future Issuance ATM Facility ATM Facility [Member] ATM Facility Schedule of Stock by Class [Table] Stock, Class of Stock [Table] Schedule of Segment Reporting Information, by Segment Schedule of Segment Reporting Information, by Segment [Table Text Block] License Agreement License Agreement [Member] Represents the pertaining information to license agreement. Inventory Disclosure [Abstract] Schedule of Cash and Cash Equivalents Schedule of Cash and Cash Equivalents [Table Text Block] Yale University Yale University [Member] Represents the information pertaining to yale university. Measurement Input Type [Domain] Measurement Input Type [Domain] Adjustment to Compensation, Amount Adjustment to Compensation Amount Collaborative Arrangement, Milestone Payments [Axis] Collaborative Arrangement, Milestone Payments [Axis] Collaborative Arrangement, Milestone Payments Number of purchasers Number of Purchasers Number of Purchasers Consolidation Consolidation, Policy [Policy Text Block] Stock-based compensation expense Share-Based Payment Arrangement, Noncash Expense Option agreement, remaining right to purchase common stock Option Agreement, Remaining Shares Authorized for Issuance, Value Option Agreement, Remaining Shares Authorized for Issuance, Value Milestone payment potentially receivable Milestone Payment Potentially Receivable Milestone Payment Potentially Receivable Exercise of options under stock plan Exercise of options outstanding under stock plans Options Share-Based Payment Arrangement, Option [Member] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Accounts and Financing Receivables [Table] Accounts and Financing Receivables [Table] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Total stockholders’ equity (deficit) Beginning balance Ending balance Equity, Attributable to Parent Measurement Frequency [Axis] Measurement Frequency [Axis] Insider Trading Policies and Procedures [Line Items] Total Share-Based Payment Arrangement, Expense Schedule of Property and Equipment Property, Plant and Equipment [Table Text Block] Common stock, shares authorized (in shares) Common stock, authorized (in shares) Common Stock, Shares Authorized Issuance of common stock (in shares) Stock Issued During Period, Shares, New Issues Current assets Assets, Current [Abstract] Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Total liabilities and stockholders’ equity (deficit) Liabilities and Equity Recurring Fair Value, Recurring [Member] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] Concentration of Credit Risk Concentration Risk, Credit Risk, Policy [Policy Text Block] LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) Liabilities and Equity [Abstract] Other income (expense), net: Other Nonoperating Income (Expense) [Abstract] Cover [Abstract] Subsequent Installment [Domain] Subsequent Installment [Domain] Subsequent Installment [Domain] Cash equivalents (money market funds) Cash and Cash Equivalents, Fair Value Disclosure Maximum Maximum [Member] Weighted average exercise price, Vested and exercisable (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price JDRF Agreement derivative liability JDRF Agreement JDRF Agreement [Member] JDRF Agreement Accounting Policies [Abstract] Non-cash interest expense Interest Expense, Interest-Bearing Liability Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Pay vs Performance Disclosure [Line Items] William (B.J.) Scheessele [Member] William (B.J.) Scheessele Trailing worldwide three-month net sales threshold Trailing Worldwide Three-Month Net Sales Threshold Trailing Worldwide Three-Month Net Sales Threshold Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Contingent cash collateral to be funded Contingent Cash Collateral To Be Funded Contingent Cash Collateral To Be Funded Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Total financial liabilities Financial Liabilities Fair Value Disclosure Amortization expense Finance Lease, Right-of-Use Asset, Amortization Entity Shell Company Entity Shell Company Contingent Consideration Tranches [Axis] Contingent Consideration Tranches [Axis] Represents the contingent consideration tranches number. Other long-term liabilities Other Liabilities, Noncurrent Statement of Stockholders' Equity [Abstract] Less current portion of revenue interest liability Long-Term Debt, Current Maturities Statement of Cash Flows [Abstract] Company Selected Measure Amount Company Selected Measure Amount Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Comprehensive income (loss) Comprehensive Income (Loss), Net of Tax, Attributable to Parent Measurement Input Type [Axis] Measurement Input Type [Axis] Name Measure Name Accrued severance obligation Restructuring Reserve Private Placement Warrants Private Placement Warrants [Member] Represents the information pertaining to private placement warrants. Schedule of Stock-Based Compensation Expense and Remaining Unrecognized Costs Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Schedule of Changes in Fair Value of Level 3 Financial Instruments Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Class of Stock [Line Items] Class of Stock [Line Items] Consolidation, Less-than-Wholly-Owned Subsidiary, Parent Ownership Interest, Effect of Change [Table] Consolidation, Less-than-Wholly-Owned Subsidiary, Parent Ownership Interest, Effect of Change [Table] Document Fiscal Period Focus Document Fiscal Period Focus Common stock purchase agreement, amount remaining Common Stock Purchase Agreement, Amount Remaining Common Stock Purchase Agreement, Amount Remaining Unsecured Debt Unsecured Debt [Member] Total Direct Expenses [Member] Direct Expenses Award Timing Method Award Timing Method [Text Block] Litigation Case [Domain] Litigation Case [Domain] Furniture and fixtures Furniture and Fixtures [Member] Award Type [Axis] Award Type [Axis] Revenue interest liability, beginning balance Revenue interest liability, ending balance Long-Term Debt Number of tranches of contingent earnout shares Reverse Recapitalization, Contingent Consideration, Liability, Number of Tranches The number of tranches of shares of combined entity that equity holders of acquiring entity are entitled to upon occurrence of triggering events. Legal Entity [Axis] Legal Entity [Axis] Total assets Assets Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Legacy Humacyte Common Stock Warrants Humacyte, Inc. [Member] Represents Humacyte, Inc. Dale Sander [Member] Dale Sander BVP Patent Rights BVP Patent Rights [Member] BVP Patent Rights Over-allotment option, period Sale of Stock, Over-Allotment Option, Period Sale of Stock, Over-Allotment Option, Period Stock-Based Compensation Share-Based Payment Arrangement [Policy Text Block] Trading Symbol Trading Symbol Contingent Earnout Liability Business Combination [Policy Text Block] Fresenius Medical Care Fresenius Medical Care [Member] Represents information pertaining to Fresenius Medical Care. Restricted Cash Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Option agreement, number of days volume-weighted average price Option Agreement, Number of Days Volume-Weighted Average Price Option Agreement, Number of Days Volume-Weighted Average Price Business Combination, Contingent Consideration [Table] Business Combination, Contingent Consideration [Table] Entity Address, City or Town Entity Address, City or Town Collaborative Arrangement, Milestone Payments [Domain] Collaborative Arrangement, Milestone Payments [Domain] Collaborative Arrangement, Milestone Payments [Domain] Cash flows from operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Percentage threshold of cumulative purchaser payments required for termination of purchase agreement Percentage Threshold of Cumulative Purchaser Payments Required for Termination of Purchase Agreement Percentage Threshold of Cumulative Purchaser Payments Required for Termination of Purchase Agreement Inventory Inventory Disclosure [Text Block] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Shares issued under agreement (in shares) Collaborative Arrangement, Shares Issued Represents the number of shares issued in connection with License agreement. Income Statement Location [Domain] Statement of Income Location, Balance [Domain] Revenue Interest Liability Activity [Roll Forward] Revenue Interest Liability Activity [Roll Forward] Revenue Interest Liability Activity William (B.J.) Scheessele - 2024 Sale Trading Plan [Member] William (B.J.) Scheessele - 2024 Sale Trading Plan Employee severance costs Severance Costs Fresenius Medical Care Deutschland GmbH Fresenius Medical Care Deutschland GmbH [Member] Fresenius Medical Care Deutschland GmbH Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Assets: Assets, Fair Value Disclosure [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Earnout Shares Earnout Shares [Member] Earnout Shares Warrants to purchase Common Stock Warrant [Member] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Outstanding awards (in shares) Options outstanding, beginning of period (in shares) Options outstanding, end of period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Level 2 Fair Value, Inputs, Level 2 [Member] Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Business Combination [Domain] Business Combination [Domain] Fresenius Medical Care Related Party [Member] Common stock, shares outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding Conversion of stock (in shares) Conversion of Stock, Shares Issued Change in fair value of derivatives (Gain) loss on remeasurement of warrants Fair Value Adjustment of Warrants Plan Name [Axis] Plan Name [Axis] Document Information [Table] Document Information [Table] PEO PEO [Member] William (B.J.) Scheessele - 2025 Trading Plan [Member] William (B.J.) Scheessele - 2025 Trading Plan Supplemental disclosure of noncash activities: Noncash Investing and Financing Items [Abstract] Interest income Investment Income, Interest Expiration period of agreement Collaborative Arrangement, Expiration Period Represents the agreement expiration term after first commercial sale. Changes in operating assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Proceeds from the exercise of stock options Stock Issued During Period, Value, Stock Options Exercised Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Market price of public stock (in dollars per share) Current stock price Measurement Input, Share Price [Member] Financing transaction Proceeds from Issuance or Sale of Equity Expected share price volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Accumulated Deficit Retained Earnings [Member] Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Effective interest rate Debt Instrument, Interest Rate, Effective Percentage Schedule of Accrued Expenses Schedule of Accrued Liabilities [Table Text Block] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Restatement Determination Date Restatement Determination Date Share-Based Payment Arrangement [Abstract] Cash, cash equivalents and restricted cash at the beginning of the period Cash, cash equivalents and restricted cash at the end of the period Total cash, cash equivalents and restricted cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Income tax expense or benefit Income Tax Expense (Benefit) Common Stock Purchase Agreement derivative asset Derivative Asset Sale of Stock [Domain] Sale of Stock [Domain] Contingent derivative liability Derivative Liability, Noncurrent Document Information [Line Items] Document Information [Line Items] Option Period [Axis] Option Period [Axis] Option Period Revenue interest liability Unsecured Debt Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Estimated dividend yield Measurement Input, Expected Dividend Rate [Member] October 2024 Registered Direct Offering October 2024 Registered Direct Offering [Member] October 2024 Registered Direct Offering Product and Service [Domain] Product and Service [Domain] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Property and equipment, gross Property, Plant and Equipment, Gross Accelerated vesting ending period Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting Ending Period Represents the end of involuntary termination term after effective date of corporate transaction. Milestone payments Milestone Payments Received Milestone Payments Received Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Business Combination [Table] Business Combination [Table] Organization, Consolidation and Presentation of Financial Statements [Abstract] Price per share (in dollars per share) Sale of Stock, Average Price Per Share Sale of Stock, Average Price Per Share Total investment amount Purchase Agreement, Total Investment Amount Purchase Agreement, Total Investment Amount Maximum contingent earnout (in shares) Reverse Recapitalization, Contingent Consideration, Liability, Shares The maximum aggregate number of shares of combined entity that equity holders of acquiring entity are entitled to upon occurrence of triggering events. Non-cash operating lease costs Operating Lease, Right-of-Use Asset, Periodic Reduction Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Closing stock price to trigger contingent earnout shares (in dollars per share) Reverse Recapitalization, Contingent Consideration, Liability, Per Share Reverse Recapitalization, Contingent Consideration, Liability, Per Share Proceeds from PIPE Financing Proceeds from Issuance of Private Placement Proceeds from the exercise of stock options Proceeds from Stock Options Exercised City Area Code City Area Code Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] All Trading Arrangements All Trading Arrangements [Member] Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Termination period Termination Period Represents the threshold notice period required to terminate the agreement. Merger Agreement Merger Agreement [Member] Merger Agreement Weighted average remaining contractual term, Vested and expected to vest (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Accrued expenses Total Accrued Liabilities, Current Exercise of option by underwriters Sale of Stock, Option [Member] Sale of Stock, Option Commitments and Contingencies Disclosure [Abstract] Class of Warrant or Right [Line Items] Class of Warrant or Right [Line Items] Accelerated vesting commencement period Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting Commencement Period Represents the commencement of involuntary termination term prior to effective date of corporate transaction. Cash flows from investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Unrecognized stock-based compensation cost Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Net cash used in operating activities Net cash used in operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Tubular Prostheses Patent Rights Tubular Prostheses Patent Rights [Member] Tubular Prostheses Patent Rights Related Party Transactions [Abstract] Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Subsequent Event Subsequent Event [Member] Schedule of Assumptions Used to Estimate Fair Value of Stock Options Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Distribution agreement, termination period Distribution Agreement, Termination Period Distribution Agreement, Termination Period Selling, general and administrative Selling, General and Administrative Expenses [Member] Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] PEO Total Compensation Amount PEO Total Compensation Amount Long-Term Debt, Type [Axis] Long-Term Debt, Type [Axis] Depreciation expense Depreciation Weighted average exercise price, Vested and expected to vest (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Cash equivalents (money market funds) Money Market Funds [Member] Equity Components [Axis] Equity Components [Axis] Entity Ex Transition Period Entity Ex Transition Period Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] October 2024 Registered Direct Offering Warrants October 2024 RDO Warrants October 2024 Registered Direct Offering Warrants [Member] October 2024 Registered Direct Offering Warrants Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Product revenue, net Symvess Product [Member] Measurement input Business Combination, Contingent Consideration, Liability, Measurement Input Number of reportable segments Number of Reportable Segments Assumptions on the date of grant to estimate the fair value of the stock options Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract] Materials and supplies Materials and Supplies [Member] Materials and Supplies Expected term (years) Warrants and Rights Outstanding, Term Other Performance Measure, Amount Other Performance Measure, Amount Weighted Average Exercise Price Per Share Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Debt issuance and transaction costs Payments of Debt Issuance Costs Inventory [Line Items] Inventory [Line Items] Schedule of Restricted Cash Restrictions on Cash and Cash Equivalents [Table Text Block] Entity Address, State or Province Entity Address, State or Province Beneficial ownership limitation percentage Class of Warrant or Right, Beneficial Ownership Limitation, Percentage Class of Warrant or Right, Beneficial Ownership Limitation, Percentage Payments of finance lease principal Finance Lease, Principal Payments Dividends, common stock Dividends, Common Stock Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Security, Excluded EPS Calculation [Table] Number of equity incentive plans Share-based Compensation Arrangement by Share-based Payment Award, Number of Plans The number of plans in share-based compensation arrangement. Related Party [Domain] Related and Nonrelated Parties [Domain] Total current liabilities Liabilities, Current Over-Allotment Option Over-Allotment Option [Member] Litigation Status [Axis] Litigation Status [Axis] Derivative Instrument [Axis] Derivative Instrument [Axis] Individual: Individual [Axis] Fair Value Measurements Fair Value of Financial Instruments, Policy [Policy Text Block] Subsequent Installment One Subsequent Installment One [Member] Subsequent Installment One Research and development Research and Development Expense [Member] Schedule of Common Stock Reserved for Future Issuances Schedule of Common Stock Reserved For Future Issuance [Table Text Block] The tabular disclosure of common stock were reserved for future issuance. Entity [Domain] Entity [Domain] Net cash used in investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Document Fiscal Year Focus Document Fiscal Year Focus Number of contingent earnout shares per tranche (in shares) Reverse Recapitalization, Contingent Consideration, Liability, Shares Per Tranche The number of shares of combined entity per tranche that equity holders of acquiring entity are entitled to upon occurrence of triggering events. Basis of Presentation and Unaudited Interim Condensed Consolidated Financial Statements Basis of Accounting, Policy [Policy Text Block] Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Effective tax rate Effective Income Tax Rate Reconciliation, Percent Entity Interactive Data Current Entity Interactive Data Current Decellularized Tissue Engineering Patent Rights Decellularized Tissue Engineering Patent Rights [Member] Decellularized Tissue Engineering Patent Rights Percentage of cumulative purchaser payments, repurchase price Percentage of Cumulative Purchaser Payments, Repurchase Price Percentage of Cumulative Purchaser Payments, Repurchase Price Plan Name [Domain] Plan Name [Domain] Unrecognized stock-based compensation cost, period for recognition Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Common Stock Warrants Warrants And Rights Outstanding, Policy [Policy Text Block] Warrants And Rights Outstanding, Policy Proceeds from the exercise of stock options (in shares) Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Equity [Abstract] Subsequent Installment Two Subsequent Installment Two [Member] Subsequent Installment Two Revenue Recognition Revenue from Contract with Customer [Policy Text Block] Aggregate intrinsic value, Vested and exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Stock Option Plan, 2005 Stock Option Plan, 2005 [Member] Represents 2005 Stock Option plan. Business Combination, Contingent Consideration, Type [Axis] Business Combination, Contingent Consideration, Type [Axis] Common Stock Purchase Agreement Derivatives, Policy [Policy Text Block] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Axis] Share accepting a tender offer entitles warrants to receive cash (as a percent) Class of Warrant or Right, Redemption Threshold The percentage of outstanding shares that accept a tender or exchange offer made that triggers entitles holders to receive cash for all warrants. Class of Warrant or Right [Table] Class of Warrant or Right [Table] Equity Increase (Decrease) in Stockholders' Equity [Roll Forward] Cure period Cure Period Cure Period Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Contingent Earnout Liability Business Combination, Contingent Consideration, Liability Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Selling, general and administrative Selling, General and Administrative Expense Expected share price volatility Measurement Input, Price Volatility [Member] Yang (Cindy) Cao - 2025 Trading Plan [Member] Yang (Cindy) Cao - 2025 Trading Plan Net sales minimum threshold for additional royalty Net Sales Minimum Threshold for Additional Royalty Net Sales Minimum Threshold for Additional Royalty Other long-term assets Other Assets, Noncurrent Accrued royalties Accrued Royalties, Current Entity Central Index Key Entity Central Index Key PEO Name PEO Name Net proceeds from issuance and sale of stock Net proceeds from sales of stock Sale of Stock, Consideration Received on Transaction Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Disposition payment percentage Disposition Payment Percentage Disposition Payment Percentage Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Public Warrants Public Warrants [Member] Represents the information pertaining to Public Warrants. Number of trading days Reverse Recapitalization, Contingent Consideration, Liability, Stock Price Trigger, Number Of Trading Days The number of days that volume-weighted average closing sale price of stock within 30 day period that triggers the earnout shares of combined entity for former holders of acquiree stocks Beginning balance Ending balance Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value First Milestone Payment First Milestone Payment [Member] First Milestone Payment Contingent Earnout Liability Business Combination, Contingent Consideration, Liability, Noncurrent Arrangement Duration Trading Arrangement Duration Omnibus Incentive Plan, 2015 Omnibus Incentive Plan, 2015 [Member] Represents 2015 Omnibus Incentive Plan. Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Weighted average expected share price volatility, maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum Computer equipment Computer Equipment [Member] Revenue Interest Liability [Line Items] Revenue Interest Liability [Line Items] Revenue Interest Liability Warrants, exercise price (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Segments [Axis] Segments [Axis] Common Stock reserved for ATM Facility Common Stock Reserved for ATM Facility [Member] Common Stock Reserved for ATM Facility Work in process Inventory, Work in Process, Net of Reserves AV Access AV Access [Member] AV Access Exercise Price Award Exercise Price Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Entity Filer Category Entity Filer Category Local Phone Number Local Phone Number Class of Stock [Domain] Class of Stock [Domain] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Price per share (in dollars per share) Share Price Inventory, Current [Table] Inventory, Current [Table] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Stock-based Compensation Share-Based Payment Arrangement [Text Block] ASSETS Assets [Abstract] Revenue interest liability, net of current portion at June 30, 2025 Long-Term Debt, Excluding Current Maturities Proceeds from Revenue Interest Purchase Agreement Proceeds from Issuance of Unsecured Debt Underlying Security Market Price Change Underlying Security Market Price Change, Percent Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Debt Instrument [Axis] Debt Instrument [Axis] Term Loan Agreement Term Loan Agreement [Member] Represents the information pertaining to term loan agreement. Fair Value Measurements Fair Value Disclosures [Text Block] Registered Direct Warrants, 180 Day, October 2024 Registered Direct Warrants, 180 Day, October 2024 [Member] Private Placement 180 Day Warrants Business Combination [Line Items] Business Combination [Line Items] Stockholders’ equity (deficit) Equity, Attributable to Parent [Abstract] Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Entity Address, Address Line One Entity Address, Address Line One Research and development Research and Development Expense Long-Term Incentive Plan, 2021 Long-Term Incentive Plan, 2021 [Member] Represents the 2021 Long-Term Incentive Plan. Common stock purchase agreement term Common Stock Purchase Agreement, Term Common Stock Purchase Agreement, Term Fair Value as of Grant Date Award Grant Date Fair Value Property, Plant and Equipment [Abstract] Entity Registrant Name Entity Registrant Name Subsequent Installment [Axis] Subsequent Installment [Axis] Subsequent Installment Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Collaborative arrangement, milestone payments Collaborative Arrangement, Milestone Payments Represents the amount of milestone payments upon achievement of certain regulatory milestones. Schedule of Revenue Interest Liability Activity Schedule of Long-Term Debt Instruments [Table Text Block] Dilutive effect of assumed conversion of options to purchase common stock (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Third Milestone Payment Third Milestone Payment [Member] Third Milestone Payment Total operating expenses Costs and Expenses William (B.J.) Scheessele - 2025 Purchase Trading Plan [Member] William (B.J.) Scheessele - 2025 Purchase Trading Plan Number of consecutive trading days Reverse Recapitalization, Contingent Consideration, Liability, Stock Price Trigger, Number of Consecutive Trading Day Period The period over which the number of days that volume-weighted average closing sale price of stock that triggers the earnout shares of combined entity for former holders of acquiree stocks. Related Party Transaction [Line Items] Related Party Transaction [Line Items] Document Quarterly Report Document Quarterly Report Total financial assets Assets, Fair Value Disclosure Schedule of Assumptions Used in the Valuations Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Counterparty Name [Domain] Counterparty Name [Domain] Number of vote per common share held Common Stock, Number of Votes Per Unit Of Shares Held Represents the number of vote per common share held. Number of operating segments Number of Operating Segments Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Weighted average remaining contractual term, outstanding (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Registered Direct Offerings Registered Direct Offerings [Member] Registered Direct Offerings Contingent cash collateral, restricted amount Contingent Cash Collateral, Agent Consent and Other Rights Contingent Cash Collateral, Agent Consent and Other Rights Revenue Interest Liability [Table] Revenue Interest Liability [Table] Revenue Interest Liability Related Party [Axis] Related and Nonrelated Parties [Axis] Title Trading Arrangement, Individual Title Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Restatement Determination Date: Restatement Determination Date [Axis] Non-PEO NEO Non-PEO NEO [Member] Aggregate intrinsic value, outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Contingent cash collateral, restricted amount Contingent Cash Collateral To Be Funded, Agent Consent and Other Rights Contingent Cash Collateral To Be Funded, Agent Consent and Other Rights Interest expense Interest expense recognized Interest Expense, Debt Sale of Stock [Axis] Sale of Stock [Axis] License fee paid Collaborative Arrangement, License Fee Paid Collaborative Arrangement, License Fee Paid Name Trading Arrangement, Individual Name Award Type [Domain] Award Type [Domain] Registered Direct Warrants, 1,640 Day, October 2024 Registered Direct Warrants, 1,640 Day, October 2024 [Member] Private Placement 1,640 Day Warrants Equity Awards Adjustments Equity Awards Adjustments [Member] Number of installments Number of Installments Number of Installments Leasehold improvements Leasehold Improvements [Member] Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] Fair Value of Warrant per share (in dollars per share) Warrants, measurement input Warrants and Rights Outstanding, Measurement Input Compensation Amount Outstanding Recovery Compensation Amount Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Estimated dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Statement of Comprehensive Income [Abstract] Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Clinical research services expense Clinical Research Services Expense Clinical Research Services Expense MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Name Awards Close in Time to MNPI Disclosures, Individual Name Severance costs paid Payments for Restructuring Restricted cash Restricted cash included in long-term assets Restricted Cash, Noncurrent Change in fair value of Contingent Earnout Liability Change in fair value of Contingent Earnout Liability Non-cash gain (loss) on remeasurement of Contingent Earnout Liability Business Combination, Contingent Consideration, Change in Contingent Consideration, Liability, Increase (Decrease) Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] ESPP Employee Stock [Member] Deposit Account Deposit Account [Member] Revenue: Revenues [Abstract] Payroll and personnel expenses Payroll and Personnel Expenses [Member] Payroll and Personnel Expenses Frenova Renal Research Frenova Renal Research [Member] Frenova Renal Research Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items] Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items] Aggregate intrinsic value, Vested and expected to vest Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Financial Instruments [Domain] Financial Instruments [Domain] Litigation Case [Axis] Litigation Case [Axis] Liability Class [Axis] Liability Class [Axis] Option agreement, minimum exercise price (in dollars per share) Option Agreement, Exercise Price Option Agreement, Exercise Price Capital Shares Reserved for Future Issuance [Domain] Capital Shares Reserved for Future Issuance [Domain] Information on capital stock reserved for future issuance. Percentage of cumulative purchaser payments Percentage Threshold of Cumulative Purchaser Payments Percentage Threshold of Cumulative Purchaser Payments Segments [Domain] Segments [Domain] Income Statement Location [Axis] Statement of Income Location, Balance [Axis] Measurement Input, Revenue Forecast, Discount Rate Measurement Input, Revenue Forecast, Discount Rate [Member] Measurement Input, Revenue Forecast, Discount Rate William (B.J.) Scheessele - 2024 Trading Plan [Member] William (B.J.) Scheessele - 2024 Trading Plan Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Subsequent Installment Three Subsequent Installment Three [Member] Subsequent Installment Three Inventory Increase (Decrease) in Inventories Inventory Inventory Inventory, Net Minimum Minimum [Member] Class of warrant or right, number of securities called by warrants or rights (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Payment Installment [Domain] Payment Installment [Domain] Payment Installment [Domain] Accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Net Income (Loss) per Share Attributable to Common Stockholders Earnings Per Share, Policy [Policy Text Block] Assumption of Publicly Traded Securities Assumption Of Publicly Traded Securities [Member] Assumption Of Publicly Traded Securities Accounts, Notes, Loans and Financing Receivable [Line Items] Accounts, Notes, Loans and Financing Receivable [Line Items] Company Selected Measure Name Company Selected Measure Name Option Purchase Agreement Option Purchase Agreement [Member] Option Purchase Agreement Revenue Interest Purchase Agreement Debt Disclosure [Text Block] Preferred stock, $0.0001 par value; 20,000,000 shares designated as of June 30, 2025 and December 31, 2024; 0 shares issued and outstanding as of June 30, 2025 and December 31, 2024 Preferred Stock, Value, Issued Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Accounts payable Accounts Payable, Current Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Net income (loss) attributable to common stockholders, diluted Net Income (Loss) Available to Common Stockholders, Diluted All Executive Categories All Executive Categories [Member] Stockholders' Equity Note [Abstract] Common stock, $0.0001 par value; 350,000,000 and 250,000,000 shares authorized as of June 30, 2025 and December 31, 2024, respectively; 156,342,893 and 130,027,509 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively Common Stock, Value, Issued Finance lease right-of-use assets, net Finance Lease, Right-of-Use Asset, after Accumulated Amortization Weighted average expected share price volatility, minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum Less: Undistributed earnings allocated to participating securities, basic Undistributed Earnings (Loss) Allocated to Participating Securities, Basic Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] November 2024 Registered Direct Offering Warrants November 2024 RDO Warrants November 2024 Registered Direct Offering Warrants [Member] November 2024 Registered Direct Offering Warrants Weighted-average shares outstanding used in computing net income (loss) per share attributable to common stockholders, diluted (in shares) Weighted-average common shares outstanding - diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Common stock purchase agreement, amount authorized, value Common Stock Purchase Agreement, Amount Authorized, Value Common Stock Purchase Agreement, Amount Authorized, Value Segments Segment Reporting, Policy [Policy Text Block] Commitments and contingencies (Note 11) Commitments and Contingencies Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Milestone payment received Purchase Agreement, Milestone Payment Received Purchase Agreement, Milestone Payment Received Upfront payment received Upfront Payment Received Upfront Payment Received Business Combination [Axis] Business Combination [Axis] Raw materials Inventory, Raw Materials and Supplies, Net of Reserves Entity Small Business Entity Small Business Payments of costs related to public offering Payments of costs related to public offering Payments of Stock Issuance Costs Period Two Period Two [Member] Period Two Income Taxes Income Tax Disclosure [Abstract] Restricted Cash and Cash Equivalent Item [Line Items] Restricted Cash and Cash Equivalent Item [Line Items] Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Document Transition Report Document Transition Report Underlying Securities Award Underlying Securities Amount Reportable Segment Reportable Segment [Member] Reportable Segment Equity Component [Domain] Equity Component [Domain] Document Period End Date Document Period End Date PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Income Taxes Income Tax Disclosure [Text Block] Second Milestone Payment Second Milestone Payment [Member] Second Milestone Payment Annual increase in available shares Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant, Annual Increase, Percent The annual increase of shares reserve for the share-based compensation plans as percent of the lesser of the number of shares of the entity's common stock outstanding on calendar year end of the preceding year and a number of shares of common stock determined by the Company's board of directors. Regulatory Milestone Regulatory Milestone [Member] Regulatory Milestone Accrued external research, development and manufacturing costs Accrued External Research Development And Manufacturing Costs, Current Carrying value as of the balance sheet date of obligations incurred through that date and payable for external research, development, and manufacturing expenses. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Number of verified stockholder derivative actions Number of Verified Stockholder Derivative Actions Number of Verified Stockholder Derivative Actions Maximum annual maintenance fee, less than Collaborative Arrangement, Maximum Annual Maintenance Fee Represents the amount of maximum annual maintenance fee. Weighted average remaining contractual term, Vested and exercisable (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Operating lease obligation Increase (Decrease) in Operating Lease Liability Yang (Cindy) Cao [Member] Yang (Cindy) Cao Document Type Document Type Level 3 Fair Value, Inputs, Level 3 [Member] Name Outstanding Recovery, Individual Name Additional paid-in capital Additional Paid in Capital Product and Service [Axis] Product and Service [Axis] Derivative Contract [Domain] Derivative Contract [Domain] Contingent Consideration by Type [Domain] Business Combination, Contingent Consideration, Type [Domain] Debt discount from embedded contingent derivative liability Debt Instrument, Debt Discount Recorded In The Period Debt Instrument, Debt Discount Recorded In The Period Proceeds from the issuance and sale of common stock Proceeds from Issuance of Common Stock Total revenue Product sales revenue Revenue from Contract with Customer, Excluding Assessed Tax Litigation Status [Domain] Litigation Status [Domain] Contingent Consideration Tranches [Domain] Contingent Consideration Tranches [Domain] Contingent consideration tranches number. All Individuals All Individuals [Member] Long-Term Debt, Type [Domain] Long-Term Debt, Type [Domain] Period Three Period Three [Member] Period Three Fair Value Disclosures [Abstract] Purchase of property and equipment Payments to Acquire Property, Plant, and Equipment Number of shares, Vested and expected to vest (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Name Forgone Recovery, Individual Name Change in fair value of derivatives Change in fair value of derivatives Unrealized Gain (Loss) on Derivatives Contractual term Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Total current assets Assets, Current Statistical Measurement [Axis] Statistical Measurement [Axis] Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Revenue Interest Purchase Agreement Revenue Interest Purchase Agreement [Member] Revenue Interest Purchase Agreement Revenue interest liability, current portion Unsecured Debt, Current Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Purchase price of common stock, percent of closing trading price Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent Common Stock reserved for Option Agreement Common stock Reserved For Option Agreement [Member] Common stock Reserved For Option Agreement Other research and development expenses Other Research and Development [Member] Other Research and Development Exercise price Measurement Input, Exercise Price [Member] Private Placement Private Placement [Member] Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Net income (loss) attributable to common stockholders, basic Net Income (Loss) Available to Common Stockholders, Basic Accrued Liabilities, Current [Abstract] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Current liabilities Liabilities, Current [Abstract] Weighted Average Remaining Contractual Term and Aggregate Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract] Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 [Member] Information pertaining to redeemable warrants exercisable for common stock. Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Consolidated Derivative Action Consolidated Derivative Action [Member] Consolidated Derivative Action Risk-free interest rate, minimum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum Level 1 Fair Value, Inputs, Level 1 [Member] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Accrued expenses Increase (Decrease) in Accrued Liabilities Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction [Table] Contingent Derivative Liability Derivatives, Embedded Derivatives [Policy Text Block] Net income (loss) per share attributable to common stockholders, diluted (in dollars per share) Net income (loss) attributable to common stockholders - diluted (in dollars per share) Earnings Per Share, Diluted Payment Installment [Axis] Payment Installment [Axis] Payment Installment Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current Contingent derivative, measurement input Embedded Derivative Liability, Measurement Input Title of 12(b) Security Title of 12(b) Security Tranche two Contingent Consideration Tranche Two [Member] Represents the information pertaining to contingent consideration tranche two. Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Number of shares issued (in shares) Sale of Stock, Number of Shares Issued in Transaction Total other income (expense), net Nonoperating Income (Expense) Stock-based compensation capitalized to inventory Employee Service Share-Based Compensation, Accumulated Compensation Costs Capitalized Employee Service Share-Based Compensation, Accumulated Compensation Costs Capitalized Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense Schedule of Securities That Could Potentially Dilute Net Loss Per Share in the Future That Were Not Included in the Computation of Diluted Net Income Loss Per Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Commitment Shares Commitment Shares [Member] Commitment Shares Percentage threshold of cumulative purchaser payments required for discontinuance of revenue interest payments Percentage Threshold of Cumulative Purchaser Payments Required for Discontinuance of Revenue Interest Payments Percentage Threshold of Cumulative Purchaser Payments Required for Discontinuance of Revenue Interest Payments Business Combination, Contingent Consideration [Line Items] Business Combination, Contingent Consideration [Line Items] Capital Shares Reserved for Future Issuance [Axis] Capital Shares Reserved for Future Issuance [Axis] The table relating to information on capital stock reserved for future issuance. Restricted Cash and Cash Equivalents [Axis] Restricted Cash and Cash Equivalents [Axis] Exercised (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Award Timing Disclosures [Line Items] Less: Undistributed earnings allocated to participating securities, diluted Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted Options available for issuance under stock plans Options Available for Issuance Under Stock Plans [Member] Represents the information on issuance of options under stock plan. License fee payable Collaborative Arrangement, License Fee Payable Collaborative Arrangement, License Fee Payable Schedule of Inventory Schedule of Inventory, Current [Table Text Block] Granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Accrued employee compensation and benefits Employee-related Liabilities, Current Measurement Frequency [Domain] Measurement Frequency [Domain] Property and Equipment, Net Property, Plant and Equipment Disclosure [Text Block] Proceeds from JDRF Agreement Proceeds from Issuance of Other Long-Term Debt Stockholders’ Equity (Deficit) and Warrants Equity [Text Block] Scientific and manufacturing equipment Scientific and Manufacturing Equipment [Member] N/A Net income (loss) Net income (loss) Net income (loss) Net Income (Loss) Attributable to Parent Expiration Date Trading Arrangement Expiration Date Pending Litigation Pending Litigation [Member] Construction in progress Construction in Progress [Member] Vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Restrictions on Cash and Cash Equivalents [Table] Restrictions on Cash and Cash Equivalents [Table] Property and equipment, net Property and equipment, net Property, Plant and Equipment, Net Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Preferred stock, shares designated (in shares) Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Numerator: Net Income (Loss) Attributable to Parent [Abstract] Adoption Date Trading Arrangement Adoption Date Reclassifications Reclassification, Comparability Adjustment [Policy Text Block] Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Accounts receivable Increase (Decrease) in Accounts Receivable Inventory Inventory, Policy [Policy Text Block] Entity Current Reporting Status Entity Current Reporting Status Expected term (years) Measurement Input, Expected Term [Member] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Loss from operations Operating losses Operating Income (Loss) Option agreement, value of shares authorized for issuance Option Agreement, Shares Authorized for Issuance, Value Option Agreement, Shares Authorized for Issuance, Value Tranche one Contingent Consideration Tranche One [Member] Represents the information pertaining to contingent consideration tranche one. Accumulated deficit Accumulated deficit Retained Earnings (Accumulated Deficit) Equity Line Financing Common Stock reserved for Common Stock Purchase Agreement Equity Line Financing [Member] Equity Line Financing Financial Instrument [Axis] Financial Instrument [Axis] Statement of Financial Position [Abstract] Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Executive Category: Executive Category [Axis] TPC Investments III LP and TPC Investment Solutions LP TPC Investments III LP and TPC Investment Solutions LP [Member] TPC Investments III LP and TPC Investment Solutions LP External services External Services [Member] External Services Vascular Trauma Vascular Trauma [Member] Vascular Trauma Finance lease obligation, current portion Finance Lease, Liability, Current Allowance for inventory obsolescence Inventory Valuation Reserves Current Fiscal Year End Date Current Fiscal Year End Date Class of Stock [Axis] Class of Stock [Axis] Number of shares of common stock called by each warrant (in shares) Class of Warrant or Right, Number of Securities Called by Each Warrant or Right Expected term of options (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Subsequent Event Type [Domain] Subsequent Event Type [Domain] Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Undrawn capacity Milestone Payment, Borrowing Capacity, Amount Undrawn Milestone Payment, Borrowing Capacity, Amount Undrawn Number of shares remaining available for grant (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Statement [Table] Statement [Table] Derivative liability Derivative Liability Expired warrants (in shares) Class of Warrant or Right, Expired Class of Warrant or Right, Expired Reduction in workforce Restructuring and Related Cost, Number of Positions Eliminated Adjustments to reconcile net income (loss) to net cash used in operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Royalty percentage Royalty Percentage of Annual Net Sales Payable Royalty Percentage of Annual Net Sales Payable Cash flows from financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Risk-free interest rate Measurement Input, Risk Free Interest Rate [Member] Finance lease obligation, net of current portion Finance Lease, Liability, Noncurrent Organization and Description of Business Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Securities that were not included in the computation of diluted net loss per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Denominator: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Changes in the fair value of the Level 3 financial instruments Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] All Adjustments to Compensation All Adjustments to Compensation [Member] Amendment Flag Amendment Flag Price per share (in dollars per share) Sale of Stock, Price Per Share Number of shares authorized (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Software Software Development [Member] Termination Date Trading Arrangement Termination Date Royalty cap, actual award multiplier One-Time Royalty, Amount, Actual Award Multiplier One-Time Royalty, Amount, Actual Award Multiplier Net cash provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Measure: Measure [Axis] Schedule of Stock Option Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Payments of transaction costs related to Revenue Interest Purchase Agreement Payments Of Transaction Costs Payments Of Transaction Costs Liabilities: Financial Liabilities Fair Value Disclosure [Abstract] Schedule of Common Stock Warrants Outstanding Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Registered Direct Warrants, 1,640 Day, November 2024 Registered Direct Warrants, 1,640 Day, November 2024 [Member] Registered Direct Warrants, 1,640 Day, November 2024 Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset [Domain] Weighted-average shares outstanding used in computing net income (loss) per share attributable to common stockholders, basic (in shares) Weighted-average common shares outstanding - basic (in shares) Weighted Average Number of Shares Outstanding, Basic Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Cost of goods sold Cost of Product and Service Sold Commercial Milestone Commercial Milestone [Member] Commercial Milestone Common stock warrant liabilities Warrants and Rights Outstanding Schedule of Earnings Per Share, Basic and Diluted Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Number of shares, Vested and exercisable (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Aggregate milestone payments potentially receivable Aggregate Milestone Payments Potentially Receivable Aggregate Milestone Payments Potentially Receivable Option Agreement liability Equity Option Equity Option [Member] Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Entity Tax Identification Number Entity Tax Identification Number Debt discount from embedded contingent derivative liability Noncash Contingent Derivative Liability Noncash Contingent Derivative Liability Options outstanding, beginning of period (in dollars per share) Options outstanding, end of period (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Beneficial ownership limitation, increased election, percentage Class of Warrant or Right, Beneficial Ownership Limitation, Increased Election, Percentage Class of Warrant or Right, Beneficial Ownership Limitation, Increased Election, Percentage Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Measurement Input, Payoff of Instrument, Discount Rate Measurement Input, Payoff Of Instrument, Discount Rate Member [Member] Measurement Input, Payoff Of Instrument, Discount Rate Member Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Common stock, shares issued (in shares) Common stock issued (in shares) Common Stock, Shares, Issued Contingent derivative liability Contingent Derivative Liability Embedded Derivative Financial Instruments, Revenue Interest Purchase Agreement [Member] Embedded Derivative Financial Instruments, Revenue Interest Purchase Agreement November 2024 Registered Direct Offering November 2024 Registered Direct Offering [Member] November 2024 Registered Direct Offering Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Option agreement, common stock issued Option Agreement, Common Stock Issued, Value Option Agreement, Common Stock Issued, Value Use of Estimates Use of Estimates, Policy [Policy Text Block] Interest expense Interest Expense, Nonoperating Trading Arrangement: Trading Arrangement [Axis] Total Shareholder Return Amount Total Shareholder Return Amount Option Period [Domain] Option Period [Domain] Option Period [Domain] Revenue interest liability, net of current portion Unsecured Long-Term Debt, Noncurrent Duke University Duke University [Member] Represents the pertaining information of duke university. Change in fair value included in other income (expense), net Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis Fair Value Measurements, Recurring and Nonrecurring [Table Text Block] Insider Trading Arrangements [Line Items] Security Exchange Name Security Exchange Name Forfeited (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Common Stock reserved for Contingent Earnout Shares Common stock reserved for Contingent Consideration Shares [Member] Represents the information pertaining to common stock reserved for Contingent Consideration Shares. Accrued Expenses Accrued Liabilities Disclosure [Text Block] The entire disclosure for Accrued Liabilities Disclosure of financial statements disclosure. Contract revenue Product and Service, Other [Member] Total liabilities Liabilities Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Axis] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] William (B.J.) Scheessele - 2025 Sale Trading Plan [Member] William (B.J.) Scheessele - 2025 Sale Trading Plan Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Operating expenses: Operating Expenses [Abstract] Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Other current liabilities Other Liabilities, Current Total Unallocated Expenses [Member] Unallocated Expenses Issuance of common stock Stock Issued During Period, Value, New Issues Statement [Line Items] Statement [Line Items] Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Cash and cash equivalents Cash and cash equivalents Cash and Cash Equivalent Counterparty Name [Axis] Counterparty Name [Axis] Number of additional shares authorized (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Risk-free interest rate, maximum Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum Common Stock Common Stock [Member] William (B.J.) Scheessele - 2024 Purchase Trading Plan [Member] William (B.J.) Scheessele - 2024 Purchase Trading Plan Fair value of embedded derivative upon issuance of debt Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Non-NEOs Non-NEOs [Member] Public Stock Offering Public Stock Offering [Member] Public Stock Offering [Member] Net (decrease) increase in cash, cash equivalents and restricted cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Accrued professional fees Accrued Professional Fees, Current